Full text is available at the source.
Recent Advances on Catalytic Asymmetric Synthesis of Molecules Bearing a Fluorine-Containing Stereogenic Carbon Center (2015–2024)
Recent Progress in Making Molecules with Fluorine-Linked Chiral Carbon Centers Using Catalysts (2015-2024)
AI simplified
Abstract
Approximately 20% of newly approved drugs contain fluorine, with only 16 out of 116 being enantiomerically pure.
- Fluorine significantly alters the properties of parent molecules, enhancing its role in drug development.
- Fluorine-containing drugs with aromatic substitutions are more prevalent than those with stereogenic center substitutions.
- Asymmetric induction for creating fluorine-containing drugs primarily relies on the chiral pool and chiral resolution methods.
- The asymmetric catalysis approach for developing these drugs remains underexplored.
- Recent innovations (2015-2024) in asymmetric methods emphasize the use of organo- or organometallic catalysts for constructing fluorine-containing stereogenic centers.
AI simplified